Evidence map›Paper›PMID 40763313›Full record

ArticleThe Journal of clinical investigation2025

An IFN/STAT1/CYBB axis defines protective plasmacytoid DC-neutrophil crosstalk in Aspergillus fumigatus-infected mice.

Yahui Guo, Mariano A Aufiero, Kathleen Am Mills, Simon A Grassmann, Hyunu Kim, Mergim Gjonbalaj, Paul Zumbo, Audrey Billips, Katrina B Mar, Yao Yu and 6 more

Abstract read
In one paragraph

Article in The Journal of clinical investigation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Yahui GuoInfectious Disease Service, Department of Medicine.
Mariano A AufieroInfectious Disease Service, Department of Medicine.
Kathleen Am MillsInfectious Disease Service, Department of Medicine.
Simon A GrassmannImmunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Hyunu KimLouis V. Gerstner Jr. Graduate School of Biomedical Sciences, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Mergim GjonbalajImmunology and Microbial Pathogenesis Graduate Program, Weill Cornell Graduate School, New York, New York, USA.
Paul ZumboApplied Bioinformatics Core, Department of Physiology and Biophysics, Weill Cornell Medicine, New York, New York, USA.
Audrey BillipsInfectious Disease Service, Department of Medicine.
Katrina B MarInfectious Disease Service, Department of Medicine.
Yao YuInfectious Disease Service, Department of Medicine.
Laura C Echeverri TiradoCenter for Immunity and Inflammation, New Jersey Medical School, Rutgers-The State University of New Jersey, Newark, New Jersey, USA.
Lena HeungDepartment of Medicine and Department of Biomedical Sciences, Women's Guild Lung Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Amariliz RiveraCenter for Immunity and Inflammation, New Jersey Medical School, Rutgers-The State University of New Jersey, Newark, New Jersey, USA.
Doron BetelApplied Bioinformatics Core, Division of Hematology and Medical Oncology, Department of Medicine, Institute for Computational Biomedicine, Weill Cornell Medicine, New York, New York, USA.
Joseph C SunImmunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Tobias M HohlInfectious Disease Service, Department of Medicine.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
The natural killer cell response against mouse cytomegalovirus infectionR01AI100874 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI Joseph Chai-Yuen Sun · 2012 to 2026
$7.4M
Mechanisms of vaccine protection against AIDS-associated Cryptococcus infectionR01AI141368 · NIAID · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI Amariliz Rivera, Chaoyang Xue · 2019 to 2026
$5.4M
Transcriptional control of NK cell metabolismR01AI155558 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI Joseph Chai-Yuen Sun · 2021 to 2026
$4.7M
INITIATION OF THE IMMUNE RESPONSE TO ASPERGILLUS FUMIGATUSR37AI093808 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI TOBIAS M HOHL · 2021 to 2026
$4.2M
IMMUNOLOGY RESEARCH TRAININGT32CA009149 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI RUDENSKY, ALEXANDER Y · 1985 to 2022
$4.0M
Antifungal Immunity and the Mechanism of Fungal Programmed Cell DeathR01AI139632 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI CRAMER, ROBERT ANDREW, HOHL, TOBIAS M · 2019 to 2023
$3.3M
Trained immunity and the regulation of anti-fungal defenseR01AI169769 · NIAID · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI Amariliz Rivera, Chaoyang Xue · 2022 to 2026
$3.1M
Regulation of Nfil3 in innate lymphocyte-mediated host immunityR01AI130043 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI SUN, JOSEPH CHAI-YUEN · 2017 to 2021
$2.8M
Fungal Pathogenicity Determinants through the Lens of Immune-Targeted Cancer TherapiesR01AI191067 · NIAID · DARTMOUTH COLLEGE · PI Robert Andrew Cramer, TOBIAS M HOHL · 2025 to 2026
$1.7M
Investigating the molecular basis of context-dependent STAT3 function in NK cellsK99AI180360 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI GRASSMANN, SIMON · 2024 to 2025
$229k
IL-1 signaling in defense against Aspergillus fumigatus infectionF31AI167511 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI MILLS, KATHLEEN · 2022 to 2024
$143k
NCI NIH HHS P30 CA008748NCI NIH HHS T32 CA009149NIAID NIH HHS F31 AI161996NIAID NIH HHS F31 AI167511NIAID NIH HHS K99 AI180360NIAID NIH HHS R01 AI100874NIAID NIH HHS R01 AI130043NIAID NIH HHS R01 AI139632NIAID NIH HHS R01 AI141368NIAID NIH HHS R01 AI155558NIAID NIH HHS R01 AI169769NIAID NIH HHS R01 AI191067NIAID NIH HHS R37 AI093808
6 · The paper itself

Abstract

Aspergillus fumigatus is the most common cause of invasive aspergillosis (IA), a devastating infection in immunocompromised patients. Plasmacytoid DCs (pDCs) regulate host defense against IA by enhancing neutrophil antifungal properties in the lung. Here, we define the pDC activation trajectory during A. fumigatus infection and the molecular events that underlie the protective pDC-neutrophil crosstalk. Fungus-induced pDC activation began after bone marrow egress and resulted in pDC-dependent regulation of lung type I and type III IFN levels. These pDC-derived products acted on type I and type III IFN receptor-expressing neutrophils and controlled neutrophil fungicidal activity and ROS production via STAT1 signaling in a cell-intrinsic manner. Mechanistically, neutrophil STAT1 signaling regulated transcription and expression of Cybb, which encodes one of 5 NADPH oxidase subunits. Thus, the results indicate that pDCs regulate neutrophil-dependent immunity against inhaled molds by controlling local expression of a subunit required for NADPH oxidase assembly and activity in the lung.

Indexed as

AspergillosisAspergillus fumigatusDendritic CellsInterferonsNADPH OxidasesNeutrophilsSTAT1 Transcription FactorAnimalsHumansLungMiceMice, Inbred C57BLMice, KnockoutNADPH Oxidase 2Signal TransductionInterferonsNADPH Oxidase 2NADPH OxidasesStat1 protein, mouseSTAT1 Transcription FactorFungal infectionsImmunologyInfectious diseaseNeutrophils

Identifiers

PMID40763313
PMCPMC12520677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.